-
Bridge Biotherapeutics readies third IPO try after clinching mega dealIndustryAug 1, 2019‘No research, development only’ company proves potential through W1.5tr license-out deal with Boehringer Ingelheim -
Avellino Labs aims to set example for Kosdaq listing of US firmsIndustryJun 30, 2019From assisting disease prevention with DNA diagnosis, company aims for potentially curing genetic diseases
MOST POPULAR
-
01COVID-19 cases surge to 583
-
Prosecution in turmoil after chief suspended02
-
03COVID-19 cases see largest daily increase since August
-
Mastermind of sex abuse ring sentenced to 40 years in prison04
-
05Calls grow over further heightened virus curbs as worst COVID-19 outbreak yet to land in S. Korea
-
Is COVID-19 like the flu?06
-
07Study says woman was reinfected with COVID-19 shortly after recovering
-
Military to ban all troops from vacationing, off-installation trips over virus concerns08
-
09Justice minister, top prosecutor headed toward legal showdown
-
[Newsmaker] ‘Loose screws on border fence sensors disabled alarm’10